-
公开(公告)号:US20100215677A1
公开(公告)日:2010-08-26
申请号:US12770682
申请日:2010-04-29
IPC分类号: A61K39/00 , G01N33/53 , C12N5/07 , A61P37/00 , A61P3/10 , A61P19/02 , A61P17/06 , A61P35/02 , A61P35/00 , A61P1/00 , C07K2/00 , C07K14/00
CPC分类号: G01N33/564 , G01N33/566 , G01N2500/02
摘要: Methods for modulating immune cell signaling are provided. In general such methods involve modulating an interaction between a PDZ protein and a PDZ ligand protein whose interaction affects the composition and/or distribution of lipid rafts in an immune cell. Modulators that enhance or inhibit such interactions are also disclosed, as well as methods of screening for such modulators.
摘要翻译: 提供了调节免疫细胞信号传导的方法。 通常,这种方法涉及调节PDZ蛋白和PDZ配体蛋白之间的相互作用,其相互作用影响免疫细胞中脂筏的组成和/或分布。 还公开了增强或抑制这种相互作用的调节剂,以及筛选这种调节剂的方法。
-
公开(公告)号:US20080166736A1
公开(公告)日:2008-07-10
申请号:US11674034
申请日:2007-02-12
申请人: Peter S. Lu , Chamorro Somoza Diaz-Sarmiento , Brian Seed , Ramnik Xavier , Brayan Allen Irving
发明人: Peter S. Lu , Chamorro Somoza Diaz-Sarmiento , Brian Seed , Ramnik Xavier , Brayan Allen Irving
CPC分类号: G01N33/564 , G01N33/566 , G01N2500/02
摘要: Methods for modulating immune cell signaling are provided. In general such methods involve modulating an interaction between a PDZ protein and a PDZ ligand protein whose interaction affects the composition and/or distribution of lipid rafts in an immune cell. Modulators that enhance or inhibit such interactions are also disclosed, as well as methods of screening for such modulators.
摘要翻译: 提供了调节免疫细胞信号传导的方法。 通常,这种方法涉及调节PDZ蛋白和PDZ配体蛋白之间的相互作用,其相互作用影响免疫细胞中脂筏的组成和/或分布。 还公开了增强或抑制这种相互作用的调节剂,以及筛选这种调节剂的方法。
-
公开(公告)号:US20200268736A1
公开(公告)日:2020-08-27
申请号:US16651163
申请日:2018-09-26
申请人: Elizaveta Leshchiner , Zhifang Cao , Jason Rush , Michael Durney , Alykhan Shamji , Daniel Graham , Stuart L. Schreiber , Ramnik Xavier
发明人: Elizaveta Leshchiner , Zhifang Cao , Jason Rush , Michael Durney , Alykhan Shamji , Daniel Graham , Stuart L. Schreiber , Ramnik Xavier
IPC分类号: A61K31/4545 , A61K31/496
摘要: Disclosed herein are compounds for the treatment of inflammatory bowel disease. Additionally, provided herein are compositions and methods for using these compounds and compositions in the treatment of inflammatory bowel disease in a subject.
-
-